The CCP2 assay, which currently is regarded as the golden standard assay, occasionally determines RA sera as ACPA-negative; however, it has been estimated that approximately 5%–8% of these sera in fact are ACPA-positive [79,84,85,86]. The gene discussed is AGBL2; the disease is rheumatoid arthritis.